Activated T lymphocytes induce PD-L1 expression on various immune cells (T lymphocytes, NK lymphocytes and macrophages) and on tumor cells; PD1 activation induces an inhibitory effect on T lymphocyte activation and attenuates the antitumor immune response. Here, PDCD1 is linked to neoplasm.